Advertisement
Home »

Toripalimab/Chemotherapy Combo Improves Outcomes in Small Cell Lung Cancer

Oct 27, 2023

REFERENCES & ADDITIONAL READING

Oronsky B, et al. J Cancer. 2022;13(9):2945–2953.

 

Liu Y, et al. EXTENTORCH: A randomized, phase III trial of toripalimab versus placebo, in combination with chemotherapy as a first-line therapy for patients with extensive stage small cell lung cancer (ES-SCLC). Abstract LBA93, ESMO 2023, 20–24 October, Madrid, Spain.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement